CH625 is a CYP4X1 inhibitor. It acts by reprogramming TAMs via CB2 and EGFR-STAT3 axis. References: Wang C, Li Y, Chen H, Huang K, Liu X, Qiu M, Liu Y, Yang Y, Yang J. CYP4X1 Inhibition by Flavonoid CH625 Normalizes Glioma Vasculature through Reprogramming TAMs via CB2 and EGFR-STAT3 Axis. J Pharmacol Exp Ther. 2018 Apr;365(1):72-83. doi: 10.1124/jpet.117.247130. Epub 2018 Feb 1. PubMed PMID: 29437915.

纯度：≥98%

CAS：123316-64-3